Vistagen Presents Fasedienol (PH94B) Safety and Exploratory Efficacy Data from Phase 3 Open-Label Social Anxiety Disorder Study at American Society for Clinical Psychopharmacology Annual Meeting - Marketscreener.com
Submitted by Anonymous (not verified) on Thu, 06/01/2023 - 12:35
